FIRST WAVE BIOPHARMA Trademark

Trademark Overview


On Thursday, November 11, 2021, a trademark application was filed for FIRST WAVE BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the FIRST WAVE BIOPHARMA trademark a serial number of 97120355. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by FIRST WAVE BIOPHARMA, INC.. The FIRST WAVE BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research and analysis; Industrial research in the field of gastroenterology, gastrohepatology, inflammatory diseases, infectious diseases, and pharmaceuticals for the treatment thereof; Pharmaceutical drug development services; Pharmaceutical research and development; Research and development in the field of pharmaceuticals and pharmaceutical therapies for the treatment of gastrointestinal (GI) diseases, inflammatory diseases, inflammatory bowel diseases (IBD), ulcerative colitis, ulcerative proctitis, Crohn's disease, immune checkpoint inhibitor-associated colitis (ICI-AC), exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis, infectious diseases, and COVID-19 gastrointestinal infections; Research in the field of biopharmaceuticals; Scientific research and development
first wave biopharma

General Information


Serial Number97120355
Word MarkFIRST WAVE BIOPHARMA
Filing DateThursday, November 11, 2021
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7146620
Registration DateTuesday, August 22, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 11, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "First Wave BioPharma" appearing above and to the right of a stylized cresting wave formed from three crescent-shaped designs. The largest crescent has a tail that extends below the mark wording, while a smaller crescent design appears to the immediate right of the largest crescent design. The smallest crescent-shaped design is positioned beneath the tail of the largest crescent.
Disclaimer with Predetermined Text"BIOPHARMA"
Goods and ServicesBiological research and analysis; Industrial research in the field of gastroenterology, gastrohepatology, inflammatory diseases, infectious diseases, and pharmaceuticals for the treatment thereof; Pharmaceutical drug development services; Pharmaceutical research and development; Research and development in the field of pharmaceuticals and pharmaceutical therapies for the treatment of gastrointestinal (GI) diseases, inflammatory diseases, inflammatory bowel diseases (IBD), ulcerative colitis, ulcerative proctitis, Crohn's disease, immune checkpoint inhibitor-associated colitis (ICI-AC), exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis, infectious diseases, and COVID-19 gastrointestinal infections; Research in the field of biopharmaceuticals; Scientific research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 18, 2021
Primary Code042
First Use Anywhere DateTuesday, August 31, 2021
First Use In Commerce DateTuesday, August 31, 2021

Trademark Owner History


Party NameFIRST WAVE BIOPHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33431

Party NameFIRST WAVE BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33431

Party NameFIRST WAVE BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33431

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, July 15, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 14, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 6, 2023USE AMENDMENT FILED
Monday, July 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 6, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, December 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 1, 2022NON-FINAL ACTION E-MAILED
Thursday, September 1, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 23, 2022ASSIGNED TO EXAMINER
Friday, November 19, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 15, 2021NEW APPLICATION ENTERED